To ensure life-saving therapies reach patients worldwide, we collaborate with export partners specializing in oncology, cardiometabolic, and infectious disease treatments along with meany other therapies. These alliances enable us to:

Scale Distribution of Innovative Therapies – By partnering with pharmaceutical distributors and importers in emerging markets, we expand access to generic  cancer drugs, next-generation cardiometabolic treatments and critical infectious disease medications (including novel antivirals and vaccines).

Overcome Supply Chain Barriers – Strategic logistics partnerships ensure temperature-controlled transport, regulatory compliance, and last-mile delivery to hospitals and clinics in regions with limited infrastructure.

Localize Manufacturing Where Possible – Collaborations with contract manufacturers in key regions help reduce costs and shorten delivery timelines for essential generic and biosimilar medicines.

These export partnerships don’t just move products—they build sustainable healthcare ecosystems, ensuring patients everywhere benefit from medical progress.